Protection product sales in the first three months of 2017 rose by 6.6% (£8.7m) to £140.2m, returning to the peak levels of 2016, according to analysis from Equifax Touchstone.
The data, which is collated from 22 protection providers, with input from more than 11,000 advisers, revealed that decreasing term with critical illness policies grew most during the quarter, up by 15.9% on the final quarter of 2016 to £13.5m. This was closely followed by term policies, which saw a 14.4% (£7.5m) increase. Meanwhile critical illness, whole of life and relevant life policies all performed favourably, with sales increasing by 4.3% (£0.2m), 2.6% (£0.2m) and 1.8% (£0.05m) respectively. Three policy types saw drops in sales, with income protection suffering most noticeably,...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes